Cameco (NYSE:CCJ) Posts Earnings Results, Beats Estimates By $0.05 EPS

Cameco (NYSE:CCJ) (TSE:CCO) announced its earnings results on Tuesday. The basic materials company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.05, Zacks reports. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The firm had revenue of $607.49 million during the quarter, compared to the consensus estimate of $598.63 million. During the same quarter in the previous year, the company posted $0.16 EPS. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis.

Here are the key takeaways from Cameco’s conference call:

• Cameco says nuclear momentum is structural, with governments focused on execution and AP1000 technology emerging as the deployment-ready benchmark that should drive long-term fuel demand.
• Progress continues on Westinghouse negotiations with the U.S. government (DOC and DOE tracks), with company involvement in supply‑chain standing‑up and the possibility of up to ~20 U.S. reactors being discussed, though definitive agreements are still in progress.
• Q1 results were in line with expectations and the company left its full-year 2026 guidance unchanged; quarter-over‑quarter gains were mainly timing and higher uranium prices rather than a structural change.
• Operations remain on plan—Canadian production tracking to guidance, JV Inkai back to planned production, and a planned extended Q3 Key Lake shutdown to tie in infrastructure; some supply‑chain cost pressures (e.g., acid) are being monitored but not expected to materially impact 2026.
• Cameco is actively managing supply via inventory and product loans (now over 4 million pounds borrowed) and advancing Global Laser Enrichment (at TRL 6) as a potential Western enrichment/conversion source, supporting long‑term supply diversification.

Cameco Stock Performance

Shares of CCJ traded up $9.27 during trading hours on Wednesday, reaching $123.73. 3,768,423 shares of the company’s stock traded hands, compared to its average volume of 3,909,235. The firm has a market capitalization of $53.89 billion, a price-to-earnings ratio of 127.56, a P/E/G ratio of 2.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.47 and a quick ratio of 1.68. The business’s fifty day simple moving average is $114.81 and its two-hundred day simple moving average is $105.52. Cameco has a twelve month low of $47.87 and a twelve month high of $135.24.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Weiss Ratings upgraded Cameco from a “hold (c)” rating to a “buy (b-)” rating in a research note on Monday, February 23rd. Canadian Imperial Bank of Commerce lifted their target price on shares of Cameco to $202.00 in a report on Monday, March 9th. Raymond James Financial restated an “outperform” rating on shares of Cameco in a report on Wednesday, January 14th. Glj Research reissued a “buy” rating and issued a $171.20 price objective (up from $100.00) on shares of Cameco in a research report on Wednesday, February 18th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $147.00 target price on shares of Cameco in a research note on Thursday, February 5th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $153.13.

Key Stories Impacting Cameco

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Cameco reported Q1 EPS of $0.34 and revenue of $607.5M, both above estimates, with materials and slide-deck details reinforcing operational execution — the core earnings beat is the primary catalyst. Cameco (CCJ) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Scotiabank raised its Cameco price target to $175 and cited accelerating demand for nuclear power—this fresh analyst confidence supports near-term upside. Scotiabank Just Hiked Cameco Price Target to $175
• Positive Sentiment: Stifel Canada reiterated a Buy and kept a C$180 target after the quarter, adding institutional support to the stock’s upward move. Cameco Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$180
• Positive Sentiment: Independent coverage and upgrades (Seeking Alpha pieces) highlight Cameco’s vertical integration, Westinghouse stake and favorable long-term uranium dynamics — reinforcing the bullish investment thesis. Cameco Corporation: Robust Q1 Results And An Attractive Valuation (Rating Upgrade)
• Neutral Sentiment: Cameco reiterated annual guidance (company says results are consistent with expectations); maintaining guidance reduces downside surprises but offers limited new upside. Cameco Reports First Quarter 2026 Results
• Neutral Sentiment: Company released the earnings slide deck and call materials for investors to review underlying metrics and segment performance (useful for due diligence). Cameco Corporation 2026 Q1 – Results – Earnings Call Presentation
• Negative Sentiment: Valuation is extended after recent gains (high trailing P/E), which could limit near-term upside or increase volatility if uranium/contract dynamics disappoint; investors should weigh price versus fundamentals before adding.

Institutional Trading of Cameco

Hedge funds and other institutional investors have recently modified their holdings of the company. Bison Wealth LLC lifted its holdings in Cameco by 16.1% in the 4th quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company’s stock valued at $1,102,000 after acquiring an additional 2,975 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Cameco in the 4th quarter worth approximately $203,000. Brooklyn Investment Group lifted its stake in Cameco by 67.6% during the third quarter. Brooklyn Investment Group now owns 2,396 shares of the basic materials company’s stock valued at $201,000 after purchasing an additional 966 shares during the last quarter. First Manhattan CO. LLC. bought a new stake in Cameco during the fourth quarter worth approximately $200,000. Finally, Parkside Financial Bank & Trust grew its position in Cameco by 17.0% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,939 shares of the basic materials company’s stock worth $177,000 after buying an additional 282 shares during the last quarter. Institutional investors own 70.21% of the company’s stock.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.